2025 ATA Risk Stratification for Papillary Thyroid Cancer: Validation Study Reveals Significant Reclassification Shifts
Posted inDiabetes & Endocrinology news Oncology

2025 ATA Risk Stratification for Papillary Thyroid Cancer: Validation Study Reveals Significant Reclassification Shifts

A retrospective study of 670 papillary thyroid carcinoma patients validates the 2025 ATA risk stratification system, demonstrating a shift toward higher-risk classifications. The new 'low-intermediate-risk' class emerges as a distinct entity with intermediate structural disease persistence risk, warranting dedicated prospective management studies.
Genetic Variant in CUBN Gene Identified as Key Risk Factor for Metformin-Induced Vitamin B12 Deficiency
Posted inDiabetes & Endocrinology Internal Medicine news

Genetic Variant in CUBN Gene Identified as Key Risk Factor for Metformin-Induced Vitamin B12 Deficiency

Researchers have identified a genetic variant in the cubilin gene (CUBN, rs1801222) that significantly increases the risk of metformin-induced vitamin B12 deficiency, with carriers of the AA genotype experiencing deficiency up to twice as fast as GG carriers. This discovery offers potential for targeted clinical monitoring in high-risk patients.
Maternal Diabetes and Early Neurodevelopment: Differential Risks Emerge Across Diabetes Types and Infant Sex
Posted inDiabetes & Endocrinology news Pediatrics

Maternal Diabetes and Early Neurodevelopment: Differential Risks Emerge Across Diabetes Types and Infant Sex

A nationwide cohort study of 466,462 infants reveals that maternal pregestational diabetes significantly increases the risk of delayed developmental milestones, with type 1 diabetes conferring the highest risk and female offspring showing particular vulnerability across language, personal-social, and gross motor domains.
Rising Tide of Primary Hyperparathyroidism: Stockholm Study Reveals Dramatic Increase in Incidence and Prevalence Over 15 Years
Posted inDiabetes & Endocrinology news

Rising Tide of Primary Hyperparathyroidism: Stockholm Study Reveals Dramatic Increase in Incidence and Prevalence Over 15 Years

A landmark population-based study spanning 2006-2020 in Stockholm, Sweden, reveals that biochemically confirmed primary hyperparathyroidism incidence increased by 52% while only half of affected patients received clinical diagnosis, highlighting significant diagnostic gaps in this treatable endocrine disorder.
Surgical Metabolic Intervention: Bariatric Surgery Transforms Outcomes in Type 1 Diabetes With Obesity
Posted inDiabetes & Endocrinology General Surgery news

Surgical Metabolic Intervention: Bariatric Surgery Transforms Outcomes in Type 1 Diabetes With Obesity

A multicenter retrospective cohort study reveals that metabolic bariatric surgery in 162 adults with type 1 diabetes and obesity achieved 29.7% weight loss at one year, reduced insulin requirements by 57%, and significantly improved glycemic and lipid profiles, suggesting MBS as a viable option for this high-risk population.
Semaglutide Shows Promise in Reducing Mental Illness Worsening in Patients with Depression and Anxiety, Swedish Study Finds
Posted inDiabetes & Endocrinology news Psychiatry

Semaglutide Shows Promise in Reducing Mental Illness Worsening in Patients with Depression and Anxiety, Swedish Study Finds

A landmark Swedish cohort study of 95,490 patients reveals that semaglutide is associated with a 42% lower risk of worsening mental illness in people with depression and anxiety, while other GLP-1 receptor agonists show varied effects. The findings suggest potential dual therapeutic benefits for metabolic and mental health conditions.
Flash Glucose Monitoring Fails to Improve Glycemic Control but Reduces Large-for-Gestational-Age Risk in Gestational Diabetes
Posted inDiabetes & Endocrinology news OB/GYN & Women's Health

Flash Glucose Monitoring Fails to Improve Glycemic Control but Reduces Large-for-Gestational-Age Risk in Gestational Diabetes

A randomized trial of 205 pregnant women with gestational diabetes found that adjunctive flash glucose monitoring did not improve time-in-range glucose measurements compared to standard self-monitoring. However, the device was associated with significantly fewer large-for-gestational-age neonates, warranting further investigation in larger studies.
Dairy-Enriched High-Protein Breakfast Enhances Circadian Gene Expression and Glycemic Control in Type 2 Diabetes
Posted inDiabetes & Endocrinology Family Medicine & Nutrition news

Dairy-Enriched High-Protein Breakfast Enhances Circadian Gene Expression and Glycemic Control in Type 2 Diabetes

A randomized crossover trial demonstrates that a dairy-enriched diet with high-protein breakfast and early daytime carbohydrate restriction significantly upregulates circadian clock genes (BMAL1, REV-ERBα, CRY1), improves glycemic metrics including fasting glucose and time in range, and reduces appetite in individuals with type 2 diabetes.
Blood Pressure Variability Emerges as Independent Predictor of Kidney Disease Progression in Type 1 Diabetes, with African Caribbean Ethnicity as Key Risk Factor
Posted inDiabetes & Endocrinology Nephrology news

Blood Pressure Variability Emerges as Independent Predictor of Kidney Disease Progression in Type 1 Diabetes, with African Caribbean Ethnicity as Key Risk Factor

A 14-year cohort study of 3,079 individuals with type 1 diabetes reveals that visit-to-visit blood pressure variability, particularly systolic blood pressure variability measured by average real variability, significantly predicts diabetic kidney disease progression. African Caribbean ethnicity emerged as an independent risk factor, with a 54% increased hazard per unit increase in systolic BP variability.
Deep Capillary Plexus Defects Emerge as a Universal Biomarker for Retinal Ischemia Across All Retinal Regions in Diabetic Retinopathy
Posted inDiabetes & Endocrinology news Ophthalmology

Deep Capillary Plexus Defects Emerge as a Universal Biomarker for Retinal Ischemia Across All Retinal Regions in Diabetic Retinopathy

Novel OCTA biomarkers reveal that geometric perfusion deficits in the deep capillary plexus serve as robust predictors of retinal nonperfusion across posterior, peripheral, and total retinal regions, while foveal avascular zone enlargement specifically reflects posterior ischemic changes in diabetes.
Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy: Synthesizing Evidence from Target Trial Emulations and Global Pharmacovigilance
Posted inClinical Updates Diabetes & Endocrinology news Ophthalmology

Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy: Synthesizing Evidence from Target Trial Emulations and Global Pharmacovigilance

This review synthesizes recent evidence regarding the association between semaglutide initiation and nonarteritic anterior ischemic optic neuropathy (NAION), contrasting high-risk findings in real-world cohort studies with neutral findings in RCT meta-analyses and exploring potential mechanistic pathways.